Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B

In patients with chronic hepatitis B (CHB), loss of hepatitis B surface antigen (HBsAg) is considered a functional cure. However, HBsAg loss is uncommon with existing therapies, and predictive factors associated with HBsAg seroreversion are unknown. Using pooled data from three phase 3 clinical tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Lok, Anna S., Zoulim, Fabien, Dusheiko, Geoffrey, Chan, Henry L.Y., Buti, Maria, Ghany, Marc G., Gaggar, Anuj, Yang, Jenny C., Wu, George, Flaherty, John F., Subramanian, G. Mani, Locarnini, Stephen, Marcellin, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939500/
https://www.ncbi.nlm.nih.gov/pubmed/31909352
http://dx.doi.org/10.1002/hep4.1436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939500/
https://www.ncbi.nlm.nih.gov/pubmed/31909352
http://dx.doi.org/10.1002/hep4.1436

Ejemplares similares